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Evidence suggests that transcranial direct current stimulation (tDCS) modulates conditioned fear memories and has effects on 
cognitive flexibility via the dopaminergic system. This study examines whether modulation of scopolamine‑induced fear memory 
deficit by anodal tDCS could be mediated by the dopaminergic system. The male NMRI mice received scopolamine, 30  min 
before fear conditioning, and showed impaired contextual memory retention. Mice subjected to left frontal anodal stimulation 
for 20 or 30 min, before fear conditioning, impaired fear memory retrieval. Anodal application for 20 min significantly decreased 
scopolamine response on fear retention, while the one applied for 30 min did not alter. Moreover, anodal stimulation for 
30  min abolished scopolamine‑induced fear memory deficit. Dopaminergic antagonists SCH23390 and sulpiride, alone or in 
combination, prevented the abolishment effect of anodal stimulation on scopolamine‑induced fear memory deficit, whereas 
they did not alter the impairing effect of scopolamine at the dose of 2 mg/kg. Our data suggest that anodal stimulation for 30 min 
abrogates the impairing effect of scopolamine on fear memory retention. This influence could be prevented by dopaminergic 
antagonists, indicating the involvement of the dopaminergic system in the effect of anodal stimulation on scopolamine‑induced 
fear memory deficit.
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INTRODUCTION
Cholinergic signaling plays an important modula‑
tory role in fear memories with high adaptive perfor‑
mance against real and potential threats (Tinsley et 
al., 2004). During contextual fear conditioning, a neu‑
tral spatial location will create fear‑related behaviors 
after being associated with an innately fearful stim‑
ulus (Maren et al., 2013). Fear‑conditioned stimuli 
increase central acetylcholine release (Acquas et al., 
1996), whereas the acetylcholine muscarinic recep‑
tor blocker scopolamine impairs the performance of 
rodents in conditioning tasks (Robinson et al., 2011; 
Wilson and Fadel, 2017). As fear memory processes al‑
ter in some psychopathologies such as posttraumatic 
Received 20 May 2020, accepted 16 March 2021
RESEARCH PAPER
Acta Neurobiol Exp 2021, 81
DOI: 10.21307/ane‑2021‑016
: 172–180
tDCS and scopolamine‑induced fear memory deficitActa Neurobiol Exp 2021, 81
stress disorder and schizophrenia (Maren et al., 2013) 
and Alzheimer’s disease and other related dementias 
(Hoefer et al., 2008), it is essential to find ways to im‑
prove it. 
Recently, studies have shown the potential thera‑
peutic effect of noninvasive transcranial direct cur‑
rent stimulation (tDCS) technique on fear memories 
(Mungee et al., 2014). Studies have found that this 
system is effective due to many factors, such as safety, 
ease of use, painlessness, as well as beneficial effects 
of the procedure, were found on the motor, sensory, 
cognitive, and emotional functions in healthy par‑
ticipants as well as in patients with neurological and 
psychiatric diseases (Brunoni et al., 2011; Nitsche and 
Paulus, 2011). The tDSC uses a weak direct current 
between two electrodes, an anode and a cathode, at‑
tached to the subject’s scalp. Anodal effects on motor 
cortex neurons is excitatory, whereas cathodal effects 
is inhibitory. Continuous stimulation for several min‑
utes induces excitability changes that last (Nitsche et 
al., 2005). Based on animal studies, it is hypothesized 
that anodal tDCS‑mediated effects shift neuronal 
resting membrane potential toward depolarization 
and increased spontaneous neuronal firing. In con‑
trast, cathodal‑mediated effects shift neuronal rest‑
ing membrane potential toward hyperpolarization 
and decreased firing (Bindman et al., 1964). Overall, 
the studies collected suggest that tDCS can modulate 
brain plasticity due to synaptic modifications with‑
in the stimulated area. Changes in plasticity‑relat‑
ed mechanisms are achieved through induction of 
long‑term potentiation (LTP) and upregulation of neu‑
roplasticity‑related proteins, such as c‑fos, brain‑de‑
rived neurotrophic factor (BDNF), or N‑methyl‑D‑as‑
partate receptors (NMDARs) (Cavaleiro et al., 2020). 
There is evidence for hemispheric lateralization of 
various cognitive functions and behaviors in the hu‑
man brain (Toga and Thompson, 2003). For example, 
the left frontal systems appear to be critical for the 
cognitive selection caused by the content of working 
memory and for context‑dependent action, the right 
frontal systems for cognitive selection driven by the 
external environment and for context‑independent 
behavior (Goldberg et al., 1994). The processing and 
expression of negative emotions such as fear display 
a right hemispheric dominance in humans (Canli et 
al., 1998). In rodents, evidence for cortical lateraliza‑
tion is sparse. Neuroendocrine and autonomic stress 
responses were shown to be different between left 
and right medial prefrontal cortex lesions in rats 
(Sullivan and Gratton, 1999). Infantile handling in‑
duced increased locomotion in  the open field test af‑
ter right hemisphere lesions (Denenberg et al., 1978). 
In the hippocampus, gene expression profiles (Klur 
et al., 2009), receptor expressions (Kawakami et al., 
2003), and long‑term potentiation/long‑term depres‑
sion and innervation patterns (Shinohara et al., 2012) 
displayed specific hemispheric asymmetries. Right 
and left hemispheric inactivation impaired learning 
and expression in spatial navigation, respectively 
(Denenberg et al., 1978). Despite these findings, Wa‑
ger et al. (2003) found no support for the hypothesis 
of overall right‑lateralization of emotional function, 
and limited support for valence‑specific lateraliza‑
tion of emotional activity in the frontal cortex. Be‑
sides, we found that tDCS over the left frontal cortex 
of mice modulates fear memory dysfunction induced 
by β1‑adrenoceptor blocker propranolol (Nasehi et al., 
2017a) or lithium (Hamdami et al., 2020). 
It has been shown that cognitive processes and 
symptomatology of diseases involving dopamine are 
sensitive to the application of tDCS over the dorso‑
lateral prefrontal cortex. It has been suggested that 
subcortical effects of frontal tDCS reach to the sub‑
cortical areas such as dopaminergic areas (Keeser et 
al., 2011; Pena‑Gomez et al., 2012). Also, Tanaka et al. 
(2013) reported increased extracellular dopamine lev‑
els in the rat striatum following tDCS. They proposed 
that tDCS has a direct and/or indirect effect on the do‑
paminergic system in the rat basal ganglia. The meso‑
corticolimbic dopaminergic pathway originating from 
the ventral tegmental area is particularly sensitive to 
fear‑arousing environmental stimuli, and has been 
associated with exaggerated responses to fear‑relat‑
ed situations (Guarraci et al., 2000; Greba et al., 2001). 
The conditioned stimuli activate dopaminergic mech‑
anisms in the neural circuits of fear consists of the 
amygdala, nucleus accumbens and prefrontal cortex 
(Louilot and Besson, 2000). The involvement of do‑
pamine receptors of the basolateral amygdala in fear 
memory dysfunction induced by activation of canna‑
binoid CB1 receptors has been demonstrated (Nasehi 
et al., 2016). 
Considering the modulatory effect of tDCS on fear 
memories and the link between tDCS stimulation and 
brain dopaminergic activation, we hypothesized that 
the dopaminergic system involves in the left frontal 
anodal stimulation on scopolamine‑induced contextual 
fear memory deficit. 
METHODS
Animals
Male NMRI mice (from the animal facility of the 
Institute for Cognitive Science Studies, Tehran, Iran), 
weighing 25–30 g, were used for this study. Mice were 
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housed in groups of eight. Housing was in a 12:12 h 
light: dark cycle (lights on at 07:00 h) with ad libitum 
access to food and water. Temperature (22±2°C) was 
monitored and maintained at a constant level through‑
out the experiment. All protocols and housing were 
approved by the Ethical Committee of Tehran Univer‑
sity of Medical Sciences and adhered to Animal Care 
and Use of Laboratory Animals (National Institutes of 
Health Publication No. 85‑23, revised 2010). 
Surgery
Mice were anesthetized with ketamine hydrochlo‑
ride/xylazine (50 mg/kg and 5 mg/kg respectively; i.p.) 
and placed in a stereotaxic apparatus. A tubular plas‑
tic jack (internal diameter: 2.1 mm and contact area: 
3.5 mm2) was surgically fixed onto the skull using den‑
tal cement one week before the stimulation protocol. 
The center of the plastic jack was positioned over the 
left frontal cortex (+1 mm anteroposterior and 1 mm 
left to the bregma, according to Paxinos and Franklin 
(2001) and fixed with dental cement. After surgery, all 
animals were allowed to recover for one week before 
undergoing tDCS. During this period, as well as during 
the electrical stimulations, mice were placed in indi‑
vidual cages.
Stimulation protocol
The jack was filled with saline solution before the 
stimulation to establish the contact area of the skull. 
The anodal electrode was screwed into the tubular 
jack. A larger conventional rubber plate electrode 
(cathode, 9.5 cm2) served as the counter electrode and 
was placed onto the ventral thorax using a jacket. The 
animals were subjected to only one session of anod‑
al tDCS for 20 or 30 min. An anodal constant current 
of 0.2 mA was applied transcranially over the fron‑
tal cortex using a DC‑stimulator (Active Dose II unit 
made in Activatek company, Taiwan). Sham animals 
were subjected to the same procedures (surgery, an‑
esthesia and electrode montage), but the current was 
not delivered. To apply tDCS in awaken mice, animals 
were restrained in a restrainer during the active or 
sham tDCS session as described (Nasehi et al., 2017a, 
2017b).
The contextual fear conditioning test 
Contextual fear conditioning and recall was con‑
ducted over two days. Briefly, the chamber for fear 
conditioning consisted of a transparent acrylic cham‑
ber (25 × 25 × 25 cm) and a stainless‑steel grid floor 
equipped with an electric shock generator. The ap‑
paratus was placed in a soundproof observation box 
(55 cm × 53 cm × 67 cm) through which an auditory 
tone (4 kHz, 35 dB) was delivered to the animal. In the 
training trial, animals were placed individually into 
the fear‑conditioning chamber and allowed to explore 
freely for 2 min. They then received an acoustic tone 
(4 kHz, 30 s, 35 dB) that co‑terminated with electric 
foot shocks (0.5 mA, 2 s). The tone‑foot shock pairing 
was repeated three times with 1‑min intervals. 30 s 
after the final foot shock delivery, the mice were re‑
turned to their home cage. 24 h after the training trial, 
mice were placed in the same chamber to provide con‑
textual stimuli and allowed to move freely for 5 min. 
The freezing behavior during the 5‑min period was 
recorded as an index of contextual memory. Freezing 
was defined as the absence of any movement, except 
for those related to respiration and recorded using 
a stopwatch. Latency to the freezing was calculated as 
the delay time until the first freezing behavior. The ex‑
periments were carried out by someone blinded to the 
experimental groups.
Experimental design
The total 136 mice were divided into various groups 
consisting of eight mice per group and two experi‑
ments were conducted: 
In experiment 1, mice were randomized into one 
of nine groups. Group I – saline (10 ml/kg); groups II 
and III – scopolamine at the doses of 0.02 and 2 mg/kg, 
respectively; groups IV and V – anodal stimulation for 
20 or 30 min, respectively; groups VI and VII – scopol‑
amine (0.02 mg/kg) with anodal stimulation for 20 or 
30 min, respectively; groups VIII and IX – scopolamine 
(2 mg/kg) with anodal stimulation for 20 or 30 min, re‑
spectively (Fig. 1). 
Experiment 2 was designed using eight groups of 
animals. The animals were divided into two sets of 
four groups. In the first set, sham mice received sco‑
polamine (2 mg/kg) plus saline (10 ml/kg), D1‑like re‑
ceptor antagonist SCH23390 (0.005 mg/kg), D2‑like re‑
ceptor antagonist sulpiride (1 mg/kg) or combination 
of SCH23390 and sulpiride. In the second set, the same 
groups were subjected to anodal stimulation for 30 min 
(Fig. 1). 
All drugs, except for sulpiride, were dissolved in sa‑
line. Sulpiride was dissolved in 5 μl acetic acid and di‑
luted with 0.9% saline and was adjusted to pH 7. In the 
contextual fear memory test, SCH23390 (0.005 mg/kg) 
and/or sulpiride (1 mg/kg) was intraperitoneally ad‑
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ministered 30 min and scopolamine infused 20 min be‑
fore tDCS stimulation.
Statistical analysis
Various comparisons among experimental groups 
were interpreted using a two‑way ANOVA test fol‑
lowed by Tukey’s post hoc multiple comparison 
tests. The freezing time percentage and latency to 
the freezing of animals in different groups were ex‑
pressed as a mean and SEM. For all experimental anal‑
yses, P<0.05 was considered significant. All data were 
analyzed with the computer program, SPSS software 
(V 21.0). The graphs were drawn with SigmaPlot (14.0) 
software. 
RESULTS 
The effects of scopolamine, anodal  
stimulation and their combination  
on contextual fear memory
Two‑way ANOVA showed a significant interac‑
tion between anodal stimulation during 20 min and 
scopolamine on the freezing time percentage (sco‑
polamine effect: F(2,42)=47.96, P<0.000; anodal effect: 
F(1,42)=120.50, P<0.000, scopolamine‑anodal interac‑
tion: F(2,42)=28.65, P<0.000; Fig. 2A) and latency to the 
freezing (scopolamine effect: F(2,42)=99.57, P<0.000; an‑
odal effect: F(1,42)=14.35, P<0.000, scopolamine‑anodal 
interaction: F(2,42)=9.76, P<0.000; Fig. 2B). Post hoc anal‑
ysis revealed that scopolamine (2 mg/kg) decreased 
the freezing time percentage and increased the laten‑
cy to the freezing. Anodal stimulation for 20 min de‑
creased the freezing time percentage compared to the 
control group. Anodal stimulation plus scopolamine 
(0.02 mg/kg) decreased the freezing time percentage 
and increased the latency to the freezing compared to 
the scopolamine (0.02 mg/kg)‑treated mice. 
Two‑way ANOVA showed a significant interaction 
between anodal stimulation during 30 min and scopol‑
amine on the freezing time percentage (scopolamine 
effect: F(2,42)=14.65, P<0.000; anodal effect: F(1,42)=0.28, 
P=0.60, scopolamine‑anodal interaction: F(2,42)=26.99, 
P<0.000; Fig. 2A) and latency to the freezing (scopol‑
amine effect: F(2,42)=442.65, P<0.000; anodal effect: 
F(1,42)=322.51, P<0.000, scopolamine‑anodal interaction: 
F(2,42)=428.72, P<0.000; Fig. 2B). Post hoc analysis showed 
that anodal stimulation for 30 min decreased the freez‑
ing time percentage compared to the control group. 
Moreover, anodal stimulation for 30 min plus scopol‑
amine (2 mg/kg) increased the freezing time percent‑
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age and decreased the latency to the freezing compared 
to scopolamine (2 mg/kg)‑treated group. 
The effects of dopamine antagonists  
with and without anodal stimulation  
on scopolamine‑induced fear  
memory dysfunction
Two‑way ANOVA showed a significant interaction 
between scopolamine‑dopamine antagonist effect 
and anodal stimulation on freezing time percentage 
(scopolamine‑dopamine antagonist effect: F(3,56)=37.74, 
P<0.000; anodal stimulation effect: F(1,56)=58.32, P<0.000; 
scopolamine‑dopamine antagonist/anodal stimula‑
tion interaction: F(3,56)=38.64, P<0.000; Fig. 3A) and la‑
tency to the freezing (scopolamine‑dopamine antag‑
onist effect: F(3,56)=5.04, P=0.004; anodal stimulation 
effect: F(1,56)=41.63, P<0.000; scopolamine‑dopamine 
antagonist/anodal stimulation interaction: F(3,56)=7.43, 
P<0.000; Fig. 3B). Post hoc analysis indicated that 
30 min anodal stimulation when applied immediately 
after scopolamine (2 mg/kg) significantly increased 
freezing time percentage and decreased latency to 
the freezing compared to scopolamine‑treated group. 
Moreover, anodal stimulation when applied after 
sulpiride + scopolamine administration decreased la‑
tency to the freezing compared to its respective group 
in the left panel. 
DISCUSSION
Here, we present the evidence that anodal stim‑
ulation over the left frontal cortex for 30 min abro‑
gates contextual fear memory deficit induced by sco‑
polamine. Moreover, the anodal application cannot 
prevent the impairing effect of scopolamine in com‑
bination with dopamine antagonists on fear memory 
retention. 
Our data revealed that the intraperitoneal scopol‑
amine administration, before fear conditioning, de‑
creased the freezing time percentage, suggesting a fear 
memory deficit. Meanwhile, the effective dose of sco‑
polamine increased latency to the freezing. It has been 
established that muscarinic cholinergic antagonism 
produces learning and memory deficits similar to the 
effects produced by hippocampal lesions (Anagnos‑
taras et al., 1995). It appears that the muscarinic an‑
tagonists disrupt the hippocampal theta rhythms and 
induce an acquisition deficit in a variety of the hippo‑
campal‑dependent tasks (Vanderwolf et al., 1977; An‑
agnostaras et al., 1999). Recent studies have indicated 
that the hippocampus has an important role in Pavlov‑
ian fear conditioning. It seems that the acquisition of 
contextual fear depends on the induction of hippocam‑
pal long‑term potentiation (LTP) (Maren et al., 1996). 
Thus, because the hippocampus receives extensive 
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Fig. 2. Effects of scopolamine, anodal stimulation and their combinations 
on fear memory retention. Data are presented as mean ±  SEM. n=8/
group. ***P<0.005, **P<0.01 and *P<0.05 compared to the scopolamine 
(0  mg/kg) group; +++P<0.001 and ++P<0.01 compared to their respective 
groups in the left panel; $$$P<0.001 compared to their respective groups 
in the left panel.
Fig. 3. Effects of SCH23390, sulpiride and their combination with or without 
anodal stimulation on scopolamine‑induced fear memory dysfunction. 
(A) 30 min anodal stimulation cannot prevent the effect of scopolamine 
in combination with dopamine receptor antagonists on fear memory 
retention. (B) tDCS + scopolamine and tDCS + sulpiride + scopolamine 
groups decreased latency to the freezing compared to their respective 
groups in the left panel. Data are presented as mean ± SEM. n=8/group. 
***P<0.005, **P<0.01 and *P<0.05 compared to their respective groups 
in the left panel. 
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cholinergic input from the medial septal nucleus (Am‑
aral and Kurz, 1985), one would expect that muscarinic 
cholinergic antagonist should disrupt contextual fear 
acquisition, at least to the extent that anticholiner‑
gic action can reduce hippocampal function. Although 
muscarinic antagonists have been shown to produce 
hyperalgesia (Ghelardini et al., 1998), there is evidence 
that scopolamine attenuates the electric shock percep‑
tion (Torquet et al., 2008). Some studies have reported 
that scopolamine does not modify the pain threshold 
in the hot plate test (Torquet et al., 2008; Laurino et al., 
2017). Based on these findings, the destructive effect of 
scopolamine on contextual fear memory does not ap‑
pear to be related to its potential effect on pain. 
tDCS has been applied to many research issues be‑
cause this stimulation technique can modulate neural 
activity in the brain painlessly and non‑invasively with 
weak electrical currents (Matsumoto and Ugawa, 2017). 
However, there are no formal safety guidelines for the 
selection of stimulus parameters in tDCS. Nevertheless, 
several papers have reported that some adverse events 
persist even after tDCS stimulation. The ongoing events 
consist of skin lesions similar to burns, which can arise 
even in healthy subjects, and mania or hypomania in pa‑
tients with depression (Brunoni et al., 2012; Matsumoto 
and Ugawa, 2017). Other limitations of the tDCS appli‑
cation are the lack of control conditions over different 
cortical areas and the lack of systematic monitoring of 
the duration of the effects (Brunoni et al., 2012). Most 
studies have examined the effect of tDCS stimulation 
over the left frontal cortex on a variety of behaviors 
(Peanlikhit et al., 2017; Pedron et al., 2017; Hamdami 
et al., 2020), but there is limited support for right‑lat‑
eralization of emotional function (Wager et al., 2003). 
On the other hand, experimental evidence suggest that 
long‑term memory processing is strictly dependent on 
the left hemisphere (Podda et al., 2016). Therefore, we 
chose to apply tDCS over the left frontal cortex. We ob‑
served that the percentage of freezing time significant‑
ly decreased by a 20 min or a 30 min anodal tDCS over 
the left frontal cortex. Overall, it has been observed that 
cathodal currents produce inhibitory effects, and thus 
hyperpolarization, whereas anodal currents increase 
excitability in the form of depolarization (Nitsche and 
Paulus, 2000; 2001). Even though many studies reported 
recovery from memory deficits following tDCS stimula‑
tion, there are some opposing reports in animal models 
of disease affecting cognition. There is evidence that 
tDCS was not able to ameliorate memory symptoms of 
a triple transgenic (3xTg) mouse model of Alzheimer’s 
disease (Gondard et al., 2019). Some authors have sug‑
gested the importance of choosing an optimal current 
intensity to modulate cortical excitability since LTP al‑
terations were dependent on current intensity (Yoon et 
al., 2012). However, many factors have been shown to 
interfere with tDCS outcomes, including the duration 
and frequency of stimulation (Liebetanz et al., 2006); 
intensity, and density of the applied current (Lieb‑
etanz et al., 2009; Jackson et al., 2017), and electrode 
size and position in the scalp. On the other hand, the 
persistence of fear memory depends on the number of 
cue‑shock pairings and the shock intensity. In a recent 
study, repeated anodal tDCS had no significant effect 
on the acquisition or retention of fear extinction in 
mice subjected to fear conditioning with 0.2 mA foot 
shock, while it significantly lowered freezing during 
the acquisition of extinction when the intensity of fear 
conditioning was 1 mA (Van Schuerbeek et al., 2021). 
Authors found that tDCS reduced generalized fear in‑
duced by contextual cues when the intensity of condi‑
tioning is high, and extinction training is limited (Van 
Schuerbeek et al., 2021). Regarding rodent models, 
data are controversial regarding fear condition. A sin‑
gle session, 20 min anodal tDCS over the right frontal 
cortex did not alter contextual fear memory retention 
in mice subjected to fear conditioning with high in‑
tensity (Manteghi et al., 2017). Additionally, another 
study described that while the anodal stimulation did 
not affect fear retrieval in mice subjected to fear con‑
ditioning with 1 mA intensity, post‑training cathodal 
stimulation improved fear memory retrieval (Nasehi et 
al., 2017b, 2017a). However, left prefrontal anodal and 
cathodal tDCS impaired the acquisition of both contex‑
tual and cued fear memory in mice subjected to fear 
conditioning with 0.5 mA intensity, which could be ex‑
plained by activity modulation of deep structures such 
as the amygdala and hippocampus (Abbasi et al., 2017). 
These conflicting findings may be due to differences 
in the intensity and frequency of tDCS stimulation and 
the shock intensity in fear conditioning. An interest‑
ing finding in this study was the destructive effect of 
20 min anodal stimulation on fear memory retention 
was much greater than 30 min. According to researches 
that focused on the systematic assessment of the effect 
of tDCS on excitability (Nitsche and Paulus, 2000), a lin‑
ear dose‑effect response is expected. However recent 
data demonstrated that the relationship between tDCS 
parameters and the measured effects is not as linear 
as we thought. For example, a 3 min and a 20 min an‑
odal tDCS decreased immobility duration in the forced 
swim test, indicating an antidepressant‑like behavior, 
whereas a 10 min did not produce any effect (Peanlikhit 
et al., 2017). Therefore, an increase in the stimulation 
duration does not seem to be a successful approach to 
increase the efficacy of tDCS. For example, the prolon‑
gation of anodal tDCS from 13 min to 26 min resulted 
in reduced motor cortex excitability, most probably 
caused by intraneuronal calcium overflow (Monte‑Silva 
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et al., 2013). Given the above evidence, it is not surpris‑
ing that 50% increasing the duration of tDCS stimula‑
tion has a different effect than the short stimulation 
time. However, determining the curve of different tDCS 
stimulation duration on fear conditioning is suggested 
to confirm the nonlinear relationship between these 
two variables. 
The obtained data revealed that anodal tDCS for 
20 min significantly decreased the response of sub‑
threshold dose of scopolamine on fear memory. In 
comparison, 30 min anodal activation abrogated the 
impairing effect of the effective dose of scopolamine 
on contextual fear memory. Furthermore, 20 min an‑
odal stimulation when applied immediately after the 
subthreshold dose of scopolamine increased latency 
to the freezing. In comparison, 30 min anodal applica‑
tion decreased latency to the freezing compared to the 
effective dose of scopolamine. Previous experiments 
have demonstrated that anodal tDCS increases cere‑
bral blood flow (Merzagora et al., 2010), and enhanc‑
es neural plasticity in the brain (Fritsch et al., 2010; 
Jiang et al., 2012). Many clinical studies have report‑
ed that anodal tDCS provides therapeutic benefits in 
patients with various neurological disorders, such as 
stroke (Hummel et al., 2005), multiple system atrophy 
(Alexoudi et al., 2018), schizophrenia (Schwippel et al., 
2018), Parkinson’s (Fregni et al., 2006) and Alzheimer’s 
(Ferrucci et al., 2008) disease. The therapeutic potential 
of anodal tDCS for cognitive decline in the rat model of 
streptozotocin‑induced diabetic (Wu et al., 2017), trau‑
matic brain injury (Yoon et al., 2016), attention defi‑
cit/hyperactivity (Leffa et al., 2015), and Alzheimer’s 
disorder (Yu et al., 2015) has been supported. There 
is evidence that anodal stimulation enhances synap‑
tic plasticity through an increased BDNF signaling in 
the motor cortex (Fritsch et al., 2010) and in subcorti‑
cal brain regions, e.g., the hippocampus (Podda et al., 
2016). It is speculated that anodal tDCS applied to the 
frontal cortex may cause an extensive effect over dis‑
tant structures, including the basal forebrain and hip‑
pocampus throughout a distributed and interconnect‑
ed cortical‑subcortical network. Neurons directly stim‑
ulated by the anodal tDCS will, in turn, modulate the 
activity of adjacent neurons and activate neuronal cir‑
cuits related to learning and memory function. So the 
influences of the anodal tDCS are potentiated. Besides, 
the release of neurotransmitters such as dopamine and 
acetylcholine are possible candidates following these 
effects of tDCS (Yu et al., 2015). tDCS potentially mod‑
ulates the function of all polarizable brain cell types in 
physiological conditions and also modulates synaptic 
plasticity abnormalities and minimizes memory and 
learning deficits in many neuropsychiatric diseases. 
Considering the neuromodulatory effect and the dif‑
ferent durations of tDCS stimulation, a duration‑de‑
pendent effect of anodal stimulation on scopolamine 
response in the contextual fear memory is suggested. 
Besides, a modulatory effect for anodal stimulation on 
scopolamine response in fear memory is proposed.
We found that 30 min anodal stimulation did not pre‑
vent the impairing effect of scopolamine plus D1‑like 
dopamine receptor antagonist SCH23390, D2‑like do‑
pamine receptor antagonist sulpiride or their combi‑
nation on contextual fear memory. It should be noted 
that dopaminergic agents alone or in combination did 
not affect the impairing effect of scopolamine. More‑
over, anodal stimulation when delivered after sulpiride 
and scopolamine administrations, decreased latency to 
freezing compared to mice who received sulpiride and 
scopolamine without anodal stimulation. These obser‑
vations showed that the dopaminergic system has a vi‑
tal role in anodal stimulation on scopolamine‑induced 
amnesia, so that inactivation of dopamine receptors 
via dopamine receptor antagonists abolished the im‑
proving effect of the anode on contextual fear memory 
dysfunction induced by scopolamine. The reciprocal 
interaction between dopaminergic systems and tDCS 
has been suggested. It is possible that the precognitive 
beneficial effects of tDCS to be mediated by modulat‑
ing of mesocorticolimbic dopamine transmission. Be‑
sides, tDCS is linked to a dopamine release within the 
prefrontal cortex (Fonteneau et al., 2018). The involve‑
ment of hippocampal and striatal dopaminergic neuro‑
transmission of spontaneously hypertensive rats in the 
improvement of short‑term memory deficits following 
anodal stimulation on the frontal cortex has been pro‑
posed by Leffa et al. (2015). According to the literature, 
dopamine antagonists have no effect on motor activity 
or pain at the dose used (Bittencourt and Takahashi, 
1997; Fredriksson and Archer, 2002; Centonze et al., 
2003; Ivanova et al., 2021). Given the above findings, it 
is not surprising to suggest that the dopaminergic sys‑
tem is involved in the positive effect of anodal stimu‑
lation on contextual fear memory dysfunction induced 
by scopolamine. This paradigm of the combining an‑
odal stimulation with dopaminergic drugs could be an 
option for treating fear memory deficits in humans.
CONCLUSION
In conclusion, the present study provides evidence 
that anodal stimulation before fear conditioning can 
protect contextual fear memory dysfunction of scopol‑
amine‑treated mice, in a duration‑dependent manner. 
It appears that the dopaminergic system is involved in 
the beneficial effect of anodal stimulation on scopol‑
amine‑induced amnesia. 
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